IL-37 inhibits IL-17 expression in CD4+ T cells from RA patients and reduces Th17 polarisation in vitro following LPS and PMA stimulation, suggesting that IL-37 may regulate aberrant immunity via Th17 cell-driven IL-17 production (35). Here, IL37 is linked to rheumatoid arthritis.